chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The morning after the vaccine, I awakened with a vestibular migraine,  Although I periodically have vestibular migraines, I don't know if this one was triggered by receiving or an ingredient in the vaccine, or if it was merely coincidental.  However, because it resulted in me spending most of the day in bed, I felt it should be reported.  The evening before (same day as the vaccine) my only reactions were a mild headache and soreness/redness at the injection site.
Patient was diagnosed with barrel syndrome, it started 6 weeks after the shot and lasted 2 weeks.  He was tired, didn't want to wake up, and weak.
He became dizzy and diaphoretic and appeared to be gasping for air. O2 sat was 98% with room air, B/P 153/83. Treated with ammonia whiffs, ice pack and taken to a treatment clinic for further evaluation.
pain and inflammation of the right axillary nodule; pain and inflammation of the right axillary nodule; Pain in the right arm; This is a spontaneous report from a contactable other healthcare professional (patient). A 30-year-old female received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL1284), via an unspecified route of administration at the right arm on 28Dec2020 11:00 at a single dose for COVID-19 immunization. Medical history includes chronic migraine and sinusitis. The patient was not pregnant at the time of vaccination. Concomitant medications were amitriptyline and cetirizine hydrochloride (ZYRTEC). On 28Dec2020, the patient experienced pain in the right arm. On 29Dec2020 23:00, approximately 40 hours later the patient experienced pain and inflammation of the right axillary nodule. The events were assessed as non-serious, did not result in death, not life threatening, did not cause/prolonged hospitalization, not disabling/incapacitating, did not cause congenital anomaly/birth defect. Treatment was not received for the adverse events. The vaccine was administered in a hospital. The patient has not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was not recovered.
ITCHINESS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced itchiness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of itchiness was not reported. This report was non-serious.
Narrative:  Patient received Jansen COVID 19 vaccine on 11 April 2021. On 25 August 2021, the patient tested positive for COVID 19 and was admitted to the hospital with COVID Pneumonia. The patient was treated with remdesivir and tocilizumab. The patient's condition improved and the patient was discharged on 30 August 2021. The EUA for the vaccine requires that any cases of COVID 19 that results in hospitalization is reported.
No problem noted after administering Tdap and MMR to pt, then wanted to discuss influenza and administered same at 10 mins later immediately after administration of same and removing needle from patient's arm, his eyes became fixed and developed seizure like tonic and clonic movements which lasted briefly about 5-6 sec. Immediately after, he was alert and oriented x 3, diaphoretic but in no apparent distress.
Loss of taste; loss of smell; Fatigued; A spontaneous report  was received from a healthcare professional concerning a  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events fatigued, loss of taste and smell.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 11 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: Not available) via unknown route for prophylaxis of COVID-19 infection.  On 12 Feb 2021, the patient experienced the events  fatigued. On 16 Feb 2021, the patient experienced the events  loss of taste and smell.  Treatment details included Not provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events, fatigued, loss of taste and smell was unknown.
PATIENT WAS GIVEN THE PNEUMOVAX 23 IN THE MORNING ON 9/14/18 AND PRESENTED AT THE PHARMACY TODAY ON  9/15/18 WITH REDNESS AROUND THE INJECTION SITE AS WELL AS WARMTH AND HER ARMPITS WERE SORE.
2/2/8-Child developed swollen ankles.  2/3/8 PM-both knees swollen & L ankle.  Knees red & hot.  2/4/8-"spots" all over body.  2/5/8-large red welts over entire body-face swollen, eyes swollen.  Instructed to have child evaluated by a physician & call back with diagnosis.  Never called back.  Left messages 2/7/08, 2/8/08 and 2/19/08.  We don't know if patient was ever seen by a doctor.
I did not have an adverse event following the vaccine. On 11/04/2022, I did not feel well with muscle aches and a cough, and I tested positive for COVID-19. I contacted my doctor and was given the prescription PAXLOVID. I finished the prescription and rebound on 11/14/2022 and my cough was worse this time. I finally tested negative on 11/21/2022. Today, I continue to have a cough.
COVID?19 Vaccine EUA, arm swelling, hard, felt very warm, red around injection sight from 1/15 thru 1/17; 1/18 black and blue through 1/23,  during this time any time taking a shower, area would burn when hot water hit area;  1/23 black and blue and rough to the touch, almost like a sunburn and area looks like it will peel
PATIENT RECIEVED FIRST SHOT ON FEBRUARY 18TH AND SHOWED NO OBVIOUS SIGNS, SYMPTOMS, OR ISSUES. PATIENT RECIEVED THE SECOND SHOT ON MARCH 11TH SHOWED NO IMMEDIATE SIGNS OR SYMPTOMS UNTIL A DAY AND A HALF LATER ON MARCH 13TH WHEN PATIENT SUDDENLY STOPPED BREATHING AND WENT INTO CARDIAC FAILURE FOR NO APPARENT REASON.
Employee (patient) received flu vaccine in left arm (deltoid), returns with 50 mm (at its longest points) red raised reaction. Complaints of soreness, skin taut, arm aching during night. Temp 97.8.
PCP visit on 10/01/2021: Patient received the first dose of her COVID-19 vaccine series on 9/21/2021 and within a few minutes of receiving the vaccine she started to develop a left-sided frontal headache. She did not have a headache prior to this and does not have headaches on a regular basis. Her left frontal headache migrated toward the other side of her forehead, and then started to involve her occipital area and posterior neck muscles. Neck pain was described as a tender spasm, and when she pressed on her neck muscles it would make her headache worse. Since that time her headache has persisted at about the same severity, and she has been using Ibuprofen intermittently which does dull the pain but does not completely resolve it. She has also tried taking caffeine, along with hot showers and massaging her neck with some improvement.  Additional symptoms include intermittent vertigo with moving her head or positional changes, mild ear fullness, visual sensitivity to screens or bright lights, and nausea. Denies fevers, chills, nasal congestion, runny nose, recent illnesses, hearing loss, ear ringing, pre-syncope, loss of consciousness, vision loss, facial droop, slurred speech, or focal areas of weakness.  Administered ketorolac 30mg injection in pt left deltoid. Pt tolerated well. Administered ondansetron ODT 4mg tablet to pt. Pt tolerated well.  Prescribed cyclobenzaprine HCI 10mg and ondansetron 4mg.
This spontaneous report was received from a physician refers to a patient of unknown age and gender. Patients concurrent conditions, medical history and concomitant medications were not reported. On an unknown date of 2014 the patient was administered the first dose in the three dose series of GARDASIL and on 06-SEP-2016 the second dose was vaccinated with GARDASIL 9, intramuscularly (lot, expiration date, dose and route of administration was not provided). The primary reporter stated that the third dose in the series was not administered (drug dose omission). No adverse effects reported. No product quality complaint (PQC) filed. No further information was provided. Additional information has been requested.
Given expired vaccine; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Given expired vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Given expired vaccine). On 28-May-2021, EXPIRED PRODUCT ADMINISTERED (Given expired vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant drug was not reported. Treatment medication was not reported.
COVID vaccine booster; fever; Arm pain; fatigue; vomiting; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 17 year-old patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Unknown Manufacturer), for COVID-19 Immunization. The following information was reported: IMMUNISATION (non-serious), outcome "unknown", described as "COVID vaccine booster"; PYREXIA (non-serious), outcome "unknown", described as "fever"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "Arm pain"; FATIGUE (non-serious), outcome "unknown", described as "fatigue"; VOMITING (non-serious), outcome "unknown", described as "vomiting".   The lot number for bnt162b2 was not provided and will be requested during follow up.
Imm on 24Jun91-on 2Jul developed rash over whole body & diarrhea.(Ax) T 103. Rash lasted 7 days. RX: APAP
pt felt flushed & warm;by evening pt feet were cold like had bad circulation & devel numbness & tingling & felt like was walking on pins;also devel weakness 19OCT96;22OCT96 exp fluttering in abd;exp memory loss, neuro c/o weakness, fatigue
04-02-08 MA administered GARDASIL vaccine.  Patient lost consciousness.  She was lowered to the floor and immediately regained consciousness.  SBP112.  She was retained at the office for 15 minutes.  Then released to home with grandmother.  (Seizure type reaction with LOC).
8 days after shot woke up with soreness, itchy, tender, hot spot on arm at injection site area.  Developed 2 inch by 2 inch red itchy rash.
10/18/99 pt reported day after given flu vax, arm, neck and back starting aching. The next day, he had hallucinations, day dreams, and he was cold. Better on Monday but noted swelling and hard knot at injection site.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date the patient was vaccinated with improperly stored dose of RECOMBIVAX HB (which had the lot # L039660, expiry date 04-FEB-2018, route, dose and anatomical place of vaccination were not provided). No adverse effects were reported. The vaccine was exposed to temperatures of 34.2 Fahrenheit 24 hours and 34.5 Fahrenheit 12 hours. No previous temperature excursion was reported. The temperature excursions were detected by a data logger. No product quality complaint (PQC) involved and no further information provided.  Additional information has been requested.
Expired Twinrix administered; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 30-year-old male patient who received HAB (Twinrix) (batch number P9LTP, expiry date 1st January 2023) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 3rd January 2023, the patient received Twinrix and Twinrix Pre-Filled Syringe Device. On 3rd January 2023, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 22-FEB-2023 Reporter's comment: The nurse reported that patient received an expired dose of Twinrix on 3rd Jan 2023.  The vaccine was expired on 1st Jan 2023.  The reporter consent to follow up via email. Additional Supportive Information: The patient received an expired dose of Twinrix, which led to expired vaccine used.
Fatigue for 8 days Depression for 8 days - I am not typically depressed but I couldn?t find any joy in activities which usually brought me pleasure.
gave a pediatric doee of Havrix to an adult patient; gave a pediatric dose of Havrix to an adult patient; This case was reported by a other health professional via call center representative and described the occurrence of underdose in a adult patient who received HAV (Havrix pediatric) for prophylaxis.   Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Havrix pediatric and Havrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Havrix pediatric and Havrix Pre-Filled Syringe Device, the patient experienced underdose and adult use of a child product. On an unknown date, the outcome of the underdose and adult use of a child product were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 12-MAY-2022 Reporter's Comments: Case was received afterhours via online. Web form submitted afterhours on 12th May 2022 and retrieved by medical information at start of business on 13th May 2022. The reporter reported that one of their nurses gave a pediatric does of Havrix to an adult patient by mistake for hepatitis A immunization.  The reporter asked should he come back in and get an adult dose instead or would this still confer some protection and reporter also asked any possible negative reactions or was it literally the same formula but just half the amount.  No further details were provided.  The reporter reported that Submitting all details as provided on form. The reporter consented to follow up. Additional supportive information: The reporter reported that an adult patient received a pediatric dose of Havrix, which led to underdose and adult use of child product.
Patient was administered the PPV23 vaccine instead of the required PPV13.  Error was not made known until the following Monday on 04/08/2019 when the billing for the visit was being implemented. Patient's parent was immediately notified by phone call of the event and plans are made for the patient to come in on 04/12/2019 for the necessary vaccine.
within 20 minutes after shot the left side of my face felt light the dentist shot me with a light does of novocaine . the left eye feels tired, tongue and lips feel slightly numb, left side of face feels strange along with a headache
pt devel approx 100 R temp 2 hrs p/vax given lasted AM of 18SEP93; pt had choking noise, color pale, grey, pt was shivering all over which lasted 2 minutes then pt started crying; pt taken to ER 16SEP93 determined had lt OM;
p/vax pt c/o pain @ inj site that noc;10/6/99 rt arm below site of inj became red, warm & edematous;10/7/99 to MD for eval-arm rt biceps area & around to elbow still red, warm, edematous;
This spontaneous report was received from a certified medical assistant who referred a currently 1-year-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with an improperly stored dose of VARIVAX (dose and route of administration were not reported) lot # N000682, date of expiration: 06-JAN-2019, for prophylaxis. There was no adverse effects reported. VARIVAX was stored between -14 Celsius degrees (C) and 10 C for 2.5 hours and between -9 C and 8 C for 3.5 hours. There was no previous temperature excursion. The digital data logger was involved in recording the excursion. Additional information has been requested.
Dry cough, chest pain/pressure, shortness of breath, fever, body soreness; 7/5/21 - started to experience chest pain/pressure, shortness of breath, dry cough; 7/14/21 - went to ER for symptoms - had blood drawn, EKG 7/16/21 - went to ER for symptoms, stayed overnight. was diagnosed with Pericarditis. - had blood drawn EKG was able to manage with Motrin - 200mg every 6 hours; 8/5/21 - went to ER for worsening symptoms, shortness of breath, chest pain, fever of 100, body soreness. had blood drawn EKG, was given magnesium.
Patient had espiratory: respiratory distress unknown cause. Onsite EMS was called vitals BP 142/82 100% O2 HR 100. Patient refused evaluation or care without transport, released agianst medical advise.
pt recvd vax; exp swollen eyes; resolved;sent to allergist & was found to be allergic to thimerosal in the vax;2nd & 3rd doses of engerix B given by allergist on 23nov93 & 27may94,respectively,w/out any adverse exp;
Patient reported her throat was scratchy, back of throat tingling, had a little cough. Skin flushed per patient. HCP on site assessed, lungs clear, vital signs stable. 10mg Zyrtec given sublingually. Patient tolerated it well. After 15 minutes, symptoms improved per patient. Vital signs stable. HCP on site reassessed. Lungs clear, airway patent. Heart rate regular rate and rhythm. Patient discharged from clinic.
Post vaccine pt started feeling crumps on the right side of the chest and in the right arm. Pt reported to feel better after moving the arm and massaging the right side of the chest. Pt reported to have had breast cancer and has experienced crumps in the same area before. Vitals obtained and monitored. Pt was released at 1515.  1507 SITTING BP 168/82 HR 76 SpO2 98%
Headache, fever, stomach and abdominal cramps, pain at injection spot, abdominal cramps were severe and lasted 48 hours. Fever lasted 48+ hours.
Patient was administered Pfizer booster (3rd dosage) on 12/3/21.  Previous Pfizer dosages were received on 12/23/20 and 1/11/21 as mandated.  I collapsed at home with loss of consciousness on 12/17/22 and was taken to Hospital by EMS, admitted overnight for suspected Seizure.  EEG completed and negative.  Prolactin levels were elevated, Neurology was consulted and suspected seizure activity.  I was given Keppra in the hospital setting.   I was not discharged home on Keppra due to being first seizure.  Follow up MRI head ordered and follow up with Neurology planned.  I then had another episode at home on 12/23/21 with total weakness to left side of body with numbness and tingling to bilateral lower extremities.  I was seen in hospital ER on 12/23/21, MRI head completed and negative.  Neurology again consulted in ER due to symptoms and elevated prolactin levels.  Determined seizure activity and diagnosis of Seizure disorder given by Neurologist.  I was given IV Keppra in ER and discharged home with Keppra prescription and follow up with Neurology.  No etiology given for new-onset of seizures.  I did discuss with Neurologist that Pfizer vaccine was received on 12/3/21.
One week after 1st vaccination, injection site again began to swell and become sore  with a red, heated,  itchy rash 3in diameter.  Also,  headache, some  diarrhea  and nausea.  First rash /sore arm lasted 36 hours after vaccination , then went away.
Pain and tingling in lower stomach and anorexia, depression worsening, malaise, somnolence.
Telephone complaint by mom 48 hours after administration of area being reddened with bump that looks like a mosquito bite.
Blood clots in urine on 04/16/21. Severe blood clotting in urine on 04/17/21. Symptoms improved on 04/18/21.
Patient came back to pharmacy and claimed her left arm was swollen, then pulled up the sleeve on her blouse to show the swelling. Patient was directed to see a doctor due to severe erythema and edema in the extremity.  Pt had cellulitis.
The nightmare was a very intense; Woke up with racing heart, throbbing head and wet pillow; Woke up with racing heart, throbbing head and wet pillow/Headache; Woke up with racing heart, throbbing head and wet pillow; I felt like I had slept for hours/not feeling myself; Low energy; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 26May2021 10:00 (Lot number: EW0187) at the age of 59 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NIGHTMARE (non-serious) with onset 26May2021 22:00, outcome "recovering", described as "The nightmare was a very intense"; PALPITATIONS (non-serious), HYPERHIDROSIS (non-serious) all with onset 26May2021 22:00, outcome "recovering" and all described as "Woke up with racing heart, throbbing head and wet pillow"; HEADACHE (non-serious) with onset 26May2021 22:00, outcome "recovering", described as "Woke up with racing heart, throbbing head and wet pillow/Headache"; FEELING ABNORMAL (non-serious) with onset 26May2021 22:00, outcome "recovering", described as "I felt like I had slept for hours/not feeling myself"; ASTHENIA (non-serious) with onset 26May2021, outcome "recovering", described as "Low energy". Therapeutic measures were not taken as a result of nightmare, palpitations, headache, hyperhidrosis, feeling abnormal, asthenia.  Additional information: The patient had no other vaccine within four weeks and no other medications received within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not have any allergies. Other medical history included good health, no issues, hardly ever get sick. Adverse event: "nightmare, 12 hrs after injection, 1 hr into sleep was woke up with racing heart, throbbing head and wet pillow. I felt like I had slept for hours. The nightmare was a very intense, I was being visited by aliens and they were trying to get the vaccine out of my body. Several days of headache and low energy, just not feeling myself. Scared to receive second doze, may go see my doctor".   No follow-up attempts are possible. No further information is expected.
My first vaccine on 4/7/21 I had a headache (beginning within 30 minutes) that lasted a few days. I took tylenol a few times each day to resolve headache. I additionally had mild achiness and fatigue which resolved within 24 hours.   My second vaccine on 5/8/21, had bad side affects that lasted for 3 months. Just over the last few days they have gone away and I am feeling like myself again.  I had a migaine that lasted a week after the second dose, which I took Sumatriptan intermittently. (20mg two times per day, per 24 hours). Had serious flu like symptoms for 3 days...chills, aches, no fever.   I have had migraines in the past, but once or twice a year only.  The long lasting side effects were brain fog, memory loss, problems seaching for words, nightly body aches, aching legs. On the the brain fog continues 3 months out.